Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 4

Research Article

Use of Chinese Medicine and Subsequent Surgery in Women with Uterine Fibroid: A Retrospective Cohort Study

Table 4

Incidence for women who received myomectomy among time lag.

Diagnosis-to-surgery period (year)CM nonusersCM users cHRa (95% CI) aHRb (95% CI)
Patients with surgeryPerson-yearsIRPatients with surgeryPerson-yearsIR

Overall207419994103.7316079074417.710.20(0.18–0.21)***0.18(0.17–0.19)***
 >0.258821992244.2714839073216.340.38(0.35–0.41)***0.33(0.30–0.36)***
 >0.57311986336.8014169070515.610.43(0.39–0.47)***0.37(0.34–0.41)***
 >15621973028.48 12859060114.18 0.50(0.45–0.55)***0.42(0.38–0.47)***
 >32531906013.27 871896709.71 0.72(0.63–0.83)***0.59(0.51–0.68)***
 ≥591183464.96 455878405.18 1.01(0.80–1.26)0.79(0.63–0.99)*

acHR: crude HR.
baHR: HR adjusted for age, occupation, area, excessive menstruation, iron-deficiency anemia, and dysmenorrhea.
* and *** .

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.